首页> 美国卫生研究院文献>Rheumatology (Oxford England) >Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study

【2h】

Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study

机译：Secukinumab持续改善银屑病关节炎的体征和症状：3期FUTURE 2研究的2年结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesTo assess long-term efficacy, safety and tolerability of secukinumab up to 104 weeks in patients with active PsA.

机译：目的评估苏金单抗对活动性PsA患者长达104周的长期疗效，安全性和耐受性。

著录项

期刊名称 Rheumatology (Oxford England)
作者
Iain B McInnes; Philip J Mease; Christopher T Ritchlin; Proton Rahman; Alice B Gottlieb; Bruce Kirkham; Radhika Kajekar; Eumorphia-Maria Delicha; Luminita Pricop; Shephard Mpofu;
展开▼
作者单位

展开▼
年(卷),期 -1(56),11
年度 -1
页码 1993–2003
总页数 11
原文格式 PDF
正文语种
中图分类免疫性疾病;
关键词
spondyloarthritis psoriatic arthritis biological therapies anti-TNF therapy interleukin long term efficacy safety joints swelling;

机译：脊柱关节炎;银屑病关节炎;生物疗法;抗TNF治疗;白介素;长期;疗效;安全性;关节;肿胀;
入库时间 2022-08-21 10:58:46

相似文献

外文文献
中文文献
专利

1. Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study [J] . Iain BMcInnes, Philip JMease, Christopher TRitchlin, Rheumatology . 2017,第11期

机译：Secukinumab持续改善银屑病关节炎的症状和症状：2年结果来自第3阶段未来的2研究
2. SECUKINUMAB SUSTAINS IMPROVEMENTS IN SIGNS AND SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH 2 YEARS (FUTURE 4) [J] . Everding A., Kivitz A., Nash P., Clinical and experimental rheumatology . 2018,第4期

机译：Secukinumab通过2年（未来4）维持银屑病关节炎患者的症状和症状的改善
3. SECUKINUMAB SUSTAINS IMPROVEMENTS IN SIGNS AND SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH 2 YEARS (FUTURE 4) [J] . Everding A., Kivitz A., Nash P., Clinical and experimental rheumatology . 2018,第4期

机译：Secukinumab通过2年（未来4）维持银屑病关节炎患者的症状和症状的改善
4. Psoriatic arthritis Clinical improvement and correlation with hormone axes in etanercept-treated patients [C] . Fabiola Atzeni, Rainer H. Straub, Maurizio Cutolo, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010

机译：依托西普治疗患者患者临床改善及与激素轴相关性
5. Appraisal of models for the study of disease progression in psoriatic arthritis [D] . Aguirre-Hernandez, Rebeca. 2000

机译：对银屑病关节炎疾病进展研究模型的评估
6. Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 study [O] . Philip J Mease, Robert Landewé, Proton Rahman, 2021

机译：Secukinumab在银屑病关节炎患者的症状和症状和低射线照相进展中提供了持续改善：2年（学习末期）结果来自未来的5研究
7. Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study [O] . Iain B McInnes, Philip J Mease, Christopher T Ritchlin, 2017

机译：Secukinumab持续改善银屑病关节炎的症状和症状：2年结果来自第3期未来的2研究

Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study

摘要

著录项

相似文献

相关主题

期刊订阅